Notice ID: fbb79d5dd498413eb2c4cd87a5e60988Combined Synopsis/Solicitation
Pharmaceutics Formulation/Chemistry Manufacturing and Controls Consulting Services for Small Molecules and/or Biologics
Archived on August 9, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−04:00
- Posted
- July 15, 2022
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 541990: All Other Professional, Scientific, and Technical Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- 75N95022Q00393
- Notice ID
- fbb79d5dd498413eb2c4cd87a5e60988
Description
The National Institute of Neurological Disorders and Stroke (NINDS) requires consulting services from senior scientific level, industry-experienced drug discovery and development consultants with expertise in Pharmaceutics Formulation/Chemistry Manufacturing and Controls (CMC) Consulting Services for Small Molecules and/or Biologics, to provide technical guidance to the National Institutes of Health’s (NIH) Blueprint Neurotherapeutics Network (BPN) program and to other NIH, neuroscience-focused drug discovery and development programs. These consulting services are needed on a part-time basis; the number of hours will vary depending on the needs, quality and complexity of an assigned project. The NIH estimates that up to four (4), part-time consultants will be required during the base period of performance and the required level of effort will be 20 to 800 hours per consultant per year. Please see Attachment 1. Statement of Work for details and specifications.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
Solicitation:
75N95022Q00393- Combined Synopsis
- 2×Combined SynopsisCurrentJul 14, 2022
Pharmaceutics Formulation/Chemistry Manufacturing and Controls Consulting Services for Small Molecules and/or Biologics
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022Q00393
Archive Date
Aug 9, 2022
Office Address
Bethesda, MD, 20892